WuXi Snaps Up Bayer's Final Drug Manufacturing Plant in Germany
WuXi Snaps Up Bayer's Final Drug Manufacturing Plant in Germany
GALWAY, IRELAND--January 28, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--China's pharmaceutical company WuXi Biologics continues its push into Europe following a deal to take over the operations of one of Bayer's final drug product manufacturing plants at the company's headquarters in Leverkusen, Germany.
Within this article: Details WuXi takeover of plant, products produced, related European investment in Ireland
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- China's WuXi Biologics Snaps up Second European Pharma Plant
- European Pharma Contract Manufacturing Market Ready to Jump, an Industrial ...
- BMS Investing $400 Million in Dublin Sterile Drug Expansion
- Weight Loss Drugs Fuel Buyouts and Plant Expansions
- Novo Nordisk Spends $11 Billion to Make More Weight Loss Drugs